New York: Icon plc (NASDAQ:ICLR) Stock Has Just Had Its Buy Rating Reiterated by Jefferies. Shares now Have a $122.0 Target

September 17, 2017 - By Adrian Erickson

 New York: Icon plc (NASDAQ:ICLR) Stock Has Just Had Its Buy Rating Reiterated by Jefferies. Shares now Have a $122.0 Target

Icon plc (NASDAQ:ICLR) Rating Reaffirmed

Jefferies now has a $122.0 target on shares of Icon plc (NASDAQ:ICLR). The target indicates a potential upside of 9.57 % from the last close price of Icon plc (NASDAQ:ICLR). This rating was disclosed to clients in a research note on Monday, 11 September.

ICON PLC (NASDAQ:ICLR) Ratings Coverage

Among 12 analysts covering Icon plc (NASDAQ:ICLR), 8 have Buy rating, 1 Sell and 3 Hold. Therefore 67% are positive. Icon plc has $128 highest and $77 lowest target. $101.50’s average target is -8.84% below currents $111.34 stock price. Icon plc had 22 analyst reports since July 29, 2015 according to SRatingsIntel. The stock of ICON PLC (NASDAQ:ICLR) has “Buy” rating given on Monday, July 31 by SunTrust. The firm earned “Mkt Underperform” rating on Thursday, June 9 by Avondale. The stock has “Buy” rating by Goldman Sachs on Friday, December 16. The stock of ICON PLC (NASDAQ:ICLR) has “Outperform” rating given on Friday, August 14 by Credit Suisse. The stock has “Buy” rating by Jefferies on Thursday, July 27. The stock of ICON PLC (NASDAQ:ICLR) earned “Buy” rating by Robert W. Baird on Thursday, June 8. The firm has “Hold” rating given on Friday, December 16 by Suntrust Robinson. The stock has “Buy” rating by Jefferies on Thursday, June 29. The rating was maintained by Robert W. Baird with “Buy” on Thursday, August 31. The stock of ICON PLC (NASDAQ:ICLR) has “Market Perform” rating given on Wednesday, October 21 by Avondale.

The stock decreased 0.22% or $0.25 on September 15, reaching $111.34. About 224,663 shares traded. ICON PLC (NASDAQ:ICLR) has risen 40.78% since September 17, 2016 and is uptrending. It has outperformed by 24.08% the S&P500.

Analysts await ICON PLC (NASDAQ:ICLR) to report earnings on October, 19. They expect $1.32 earnings per share, up 10.92 % or $0.13 from last year’s $1.19 per share. ICLR’s profit will be $71.37 million for 21.09 P/E if the $1.32 EPS becomes a reality. After $1.31 actual earnings per share reported by ICON PLC for the previous quarter, Wall Street now forecasts 0.76 % EPS growth.

ICON public limited company is a contract research organization , which is engaged in providing outsourced development services to the pharmaceutical, biotechnology and medical device industries. The company has market cap of $6.02 billion. The Firm is engaged in the strategic development, management and analysis of programs that support the various stages of the clinical development process, from compound selection to Phase I-IV clinical studies. It has a 22.6 P/E ratio. The Company’s services include clinical trials management, biometric activities, consulting, imaging, contract staffing, informatics and laboratory services.

More news for ICON PLC (NASDAQ:ICLR) were recently published by: Seekingalpha.com, which released: “Icon PLC: A Hidden Gem In An Uncertain Industry” on August 29, 2017. Streetinsider.com‘s article titled: “BofA/Merrill Lynch Starts ICON plc (ICLR) at Buy” and published on September 11, 2017 is yet another important article.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: